Femasys (NASDAQ:FEMY) Stock Price Up 0.1% – What’s Next?

Femasys Inc. (NASDAQ:FEMY) shares traded up 0.1% during trading on Monday . The stock traded as high as $0.60 and last traded at $0.5948. 629,160 shares were traded during mid-day trading, a decline of 52% from the average session volume of 1,300,342 shares. The stock had previously closed at $0.5943.

Analyst Ratings Changes

Several equities research analysts recently commented on FEMY shares. Laidlaw assumed coverage on shares of Femasys in a research report on Thursday, November 20th. They issued a “buy” rating and a $6.50 price target for the company. Wall Street Zen lowered Femasys from a “hold” rating to a “sell” rating in a report on Saturday, December 20th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Femasys in a report on Wednesday, October 8th. Three research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $6.83.

Femasys Stock Up 0.1%

The company has a current ratio of 1.16, a quick ratio of 0.61 and a debt-to-equity ratio of 0.01. The business’s fifty day moving average price is $0.80 and its two-hundred day moving average price is $0.70. The firm has a market cap of $34.78 million, a P/E ratio of -0.83 and a beta of -2.54.

Femasys (NASDAQ:FEMY) last posted its earnings results on Friday, November 14th. The company reported ($0.10) EPS for the quarter, topping the consensus estimate of ($0.12) by $0.02. Femasys had a negative net margin of 960.80% and a negative return on equity of 764.26%. The firm had revenue of $0.73 million for the quarter, compared to the consensus estimate of $1.35 million. As a group, equities research analysts anticipate that Femasys Inc. will post -0.86 EPS for the current year.

Institutional Investors Weigh In On Femasys

Several institutional investors and hedge funds have recently added to or reduced their stakes in FEMY. Clear Creek Financial Management LLC boosted its position in Femasys by 4.2% during the second quarter. Clear Creek Financial Management LLC now owns 281,821 shares of the company’s stock worth $272,000 after purchasing an additional 11,450 shares during the period. Jane Street Group LLC acquired a new stake in shares of Femasys in the second quarter worth $82,000. Finally, Osaic Holdings Inc. bought a new stake in shares of Femasys during the 2nd quarter worth $45,000. 65.27% of the stock is currently owned by institutional investors and hedge funds.

About Femasys

Femasys International, Inc is a medical device company focused on the research, development and commercialization of innovative technologies for interventional women’s health applications. The company’s core activities center on creating minimally invasive diagnostic and therapeutic products designed to address uterine cavity evaluation and treatment and to improve outcomes in gynecological care.

The company’s flagship product, the FemVue® hydrosonography system, is a single-use catheter-based device that enhances visualization of the uterine cavity through saline infusion sonography.